Venlor (Venlafaxine)

Venlor (Venlafaxine): Patient-Friendly Product Information for Australia

1. Basic Product Information

2. How Venlor (Venlafaxine) Works

For everyone: Venlor belongs to a group of medicines called serotonin and noradrenaline reuptake inhibitors (SNRIs). It helps rebalance chemicals in the brain—serotonin and noradrenaline—that play a key role in mood, emotion, and energy.

For specialists: Venlafaxine acts by inhibiting the reuptake of both 5-HT (serotonin) and noradrenaline (norepinephrine) at synaptic clefts. At lower doses, it predominantly affects serotonin; higher doses also influence noradrenaline and, to a lesser extent, dopamine.

• This multi-mechanism approach is effective for resistant depression, anxiety conditions, and pain syndromes.
• Unlike tricyclic antidepressants, Venlor has minimal activity at other receptors (muscarinic, histaminergic), resulting in fewer "sedative" or anticholinergic side effects.

3. Pharmacokinetics: How Venlor Is Processed

• Absorption: Well-absorbed from the gastrointestinal tract. Peak blood concentrations reached within 2-4 hours (IR) or about 7-8 hours (XR).
• Metabolism: Primarily processed in the liver by CYP2D6 and CYP3A4 enzymes to active metabolite, O-desmethylvenlafaxine (ODV).
• Elimination: Most of the medicine leaves the body through the kidneys (urine), as both parent drug and ODV.
• Duration of action: XR (extended-release) form provides steady effects for 24 hours; IR needs twice daily dosing.

4. Use in Everyday Life & Best Practices (English/Australia Context)

• Typical starting dose: 37.5 mg or 75 mg daily (XR, taken once daily; standard released divided into two doses).
• Common maintenance dose: 75–225 mg once daily. Some severe cases require up to 375 mg under specialist supervision.
• How to use: Take at the same time each day (morning preferred; see below), with or without food. Swallow capsules/tablets whole—do not crush or chew.
• English context: For many Australians, Venlor is funded by the Pharmaceutical Benefits Scheme (PBS) for specific mental health conditions when approved by your GP or mental health specialist.

5. Morning vs. Evening Dosing

• Morning dosing: Recommended, as Venlor can increase alertness and disturb sleep in some patients.
• Evening dosing: May suit patients with daytime drowsiness, but could worsen insomnia.
• Tips: Take at a consistent daily time. If you forget, take it as soon as possible, unless it is close to the next dose (never double the dose).
• Speak to your GP or pharmacist if you’re unsure which time is best for you.

6. Taking Venlor with Food or on an Empty Stomach

• Can be taken with or without food.
• With meals: May reduce risk of nausea, especially during the first week of treatment.
• Fits easily into typical Australian diets (e.g., breakfast cereals or morning tea).
• Avoid grapefruit or grapefruit juice, which can affect liver metabolism of Venlor.

7. Warnings and Interactions

8. Indications (When is Venlor Used?)

9. Dosing by Patient Group or Condition

10. Safety Profile & Side Effects

• Nausea or upset stomach (usually passes after 1-2 weeks)
• Dry mouth
• Reduced appetite
• Headache
• Drowsiness or insomnia
• Increased sweating
• Slight increase in blood pressure (especially above 225 mg)
• Mild sexual dysfunction

• Changes in cholesterol
• Restlessness, agitation, or abnormal dreams
• Blood pressure spikes
• Hyponatraemia (low sodium, especially in elderly)
• Serotonin syndrome (with drug interactions—rare but serious)
• Eye problems (angle-closure glaucoma risk)

• May increase suicidality especially in youths and young adults. Extra monitoring recommended in first 6 weeks.
• Gradual tapering needed on stopping—do not stop suddenly.
• Pregnancy/breastfeeding: use only on clinical advice and when clearly needed.

11. Proper Use: Key Advice for Australia Patients

• Take your medicine as prescribed—do not share or change doses without your doctor’s advice.
• Store at below 25°C, away from sunlight and moisture.
• Contact a health professional if you miss more than one dose, develop severe side effects, or feel suddenly worse.
• Most side effects ease with time. If troublesome, your GP or pharmacist can suggest ways to reduce them.
• If you plan overseas travel, check legality and customs rules for venlafaxine in your destination.
• Keep out of reach of children.

12. Alternative Treatments: Overview of Options in Australia

• SSRIs (e.g. sertraline, escitalopram, fluoxetine): First-line for most depressive and anxiety conditions; usually well-tolerated, fewer blood pressure effects, but may be less effective in severe/refractory cases.
• Other SNRIs (e.g. duloxetine): Similar benefits and risks, with specific approval for neuropathic pain.
• Tricyclic antidepressants (e.g. amitriptyline): Effective but have more side effects, especially in older adults.
• Mirtazapine: Good for depression with insomnia or weight loss, but can cause drowsiness and increased appetite.
• Psychological therapy: Cognitive behavioural therapy (CBT) is PBS-subsidised and often more effective when combined with medication.

13. Legal, Regulatory & Reimbursement Status in Australia

• Regulatory authority: Therapeutic Goods Administration (TGA)
• Legal classification: Schedule 4 (S4) – Prescription Only Medicine
• PBS reimbursement: Yes, for depression and eligible anxiety disorders; copayments apply (approx. $7 for concession; $30 for general script, as of 2024) – PBS site.
• Script requirements: Australian prescription from a registered medical practitioner; repeats as directed.
• NFZ (corresponding national fund in AU): PBS and Medicare coverage for recommended indications.
• Registration: TGA-approved since 1998 in Australia.

14. Latest Research & Clinical Guidance (2022–2025)

• Royal Australian and New Zealand College of Psychiatrists (RANZCP) 2022–2024: Venlafaxine remains a key option for moderate-to-severe depression and select anxiety states, particularly when SSRIs are ineffective or not tolerated. Solid evidence for remission of symptoms and improved daily functioning.
• Cochrane Reviews (2023): Venlafaxine is as effective as SSRIs, with a slightly higher risk of discontinuation symptoms. SNRIs can be superior for severe cases or where pain syndromes overlap.
• TGA/EMA/Safety notices: Emphasis on careful blood pressure monitoring, especially at doses above 225 mg, and ongoing vigilance for suicide risk in the first weeks of therapy.
• Emerging data: Venlafaxine and its major metabolite are both active; slow/gradual dose reduction remains best practice to avoid withdrawal.

Key sources: RANZCP Clinical Practice Guidelines (2024), TGA Product Information, PBS prescribing advice, Cochrane Database (2023)

15. Availability & Delivery

Venlor is widely stocked in Australian community and online pharmacies.

16. Frequently Asked Questions (FAQ)

1. How quickly will I feel better after starting Venlor?
   Most people notice an improvement in mood, energy, or reduced anxiety within 2–4 weeks. Maximum benefit may take up to 8 weeks. Stay in touch with your healthcare professional during this period.
2. Can I drink alcohol while taking Venlor?
   It’s safest to avoid alcohol, especially in the early weeks, as both can heighten drowsiness, dizziness, and risk of side effects.
3. What should I do if I miss a dose?
   Take the missed dose as soon as you remember unless it is almost time for your next dose. Do not double up. Contact your pharmacist or GP if you miss two or more doses.
4. Is Venlor addictive or habit-forming?
   No. Venlor is not a habit-forming medicine. However, it must not be stopped suddenly—withdrawal symptoms can occur if discontinued abruptly.
5. Can I take Venlor if I am pregnant or breastfeeding?
   It should only be used during pregnancy or breastfeeding following discussion with your doctor, weighing the benefits and possible risks to you and your baby.

This information is intended for Australian patients and should complement, not replace, advice from your doctor, pharmacist, or healthcare provider.